Genus PLC (GNS)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
2,545.00p
Buy
2,555.00p
90.00p (+3.67%)
Prices updated at 02 Apr 2026, 17:00 BST
| Prices minimum 15 mins delay
Prices in GBX
Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Iain George Thomas Ferguson CBE
CEO
Mr. Jorgen Kokke
Most recent earnings
30 Jun 2025
Fiscal year end
30 Jun 2025
Employees
3,300
Head office
Matrix House
Basingstoke
United Kingdom
RG21 4FF
Key personnel
Owner name | Salary |
|---|---|
Ms. Lesley Mary Samuel Knox OBE Non-Executive Director, Senior Independent Director; Workforce Engagement Director | - |
Mr. Iain George Thomas Ferguson CBE Non-Executive Director, Chairman | - |
Dr. Celia Frances Baxter Non-Executive Director | - |
Mr. Andy Russell Executive Director, Chief Financial Officer | - |
Mr. Jorgen Kokke Executive Director, Chief Executive Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Capital Research and Management Company | 1,841,731 |
| Jupiter Unit Trust Managers Ltd | 1,595,952 |
| European Opportunities Trust | 1,595,952 |
| T. Rowe Price | 1,508,759 |
| Wellington Management International Ltd | 1,455,413 |
Director dealings
Date | Action |
|---|---|
| 27 Feb 2026 | Purchase |
| 25 Sep 2025 | Exercise of Option |
| 25 Sep 2025 | Sale of Option |
| 10 Sep 2025 | Transfer in |
| 10 Sep 2025 | Transfer in |
| 10 Sep 2025 | Transfer in |
Please note that past performance is not a reliable indicator of future returns.